MULTIPLE MYELOMA (MM)
Clinical trials for MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune cell attack on Hard-to-Treat myeloma begins early testing
Disease control Not yet recruitingThis early-phase study tests a new treatment called LVIVO-TaVec400 for people with multiple myeloma that has returned or not responded to standard therapies. About 38 adults will receive the therapy to see if it is safe and to find the best dose. The treatment uses specially modi…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 09:57 UTC
-
New drug combo aims to improve myeloma treatment and maybe skip transplant
Disease control Not yet recruitingThis study tests a new drug, linvoseltamab, added to standard chemotherapy for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. Researchers want to see if the new combination works better than the current standard treatment, and whether it…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE2, PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:55 UTC
-
New hope for tough myeloma: BR101 injection enters first human tests
Disease control Not yet recruitingThis study tests a new drug called BR101 in 10 adults with multiple myeloma that has returned or not responded to prior treatments. The main goals are to find the safest dose and check for side effects. Researchers will also look at whether the drug helps shrink or control the ca…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
New hope for Tough-to-Treat myeloma: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug called CM336 against standard treatments for people with multiple myeloma whose cancer has returned or stopped responding after at least two prior therapies. About 280 adults will be randomly assigned to receive either CM336 or a standard treatment cho…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE3 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New hope for Hard-to-Treat myeloma? early trial launches for QI-019A
Disease control Not yet recruitingThis early-phase study tests a new drug called QI-019A in 24 people with multiple myeloma that has returned or stopped responding to at least two prior treatments. The main goal is to check the drug's safety and find the right dose. Researchers will also look at whether the drug …
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New multiple myeloma drug faces off against standard treatment in phase 1 trial
Disease control Not yet recruitingThis study tests whether a new drug called HLX15-SC works similarly to the approved drug DARZALEX FASPRO® for people with newly diagnosed multiple myeloma who cannot have a stem cell transplant. About 258 participants will receive either the new drug or the approved one, along wi…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for tough blood cancers: BT02 trial launches
Disease control Not yet recruitingThis study tests a new drug called BT02 in people with blood cancers (leukemia, lymphoma, or multiple myeloma) that have returned or not responded to treatment. About 116 adults aged 18 to 70 will receive the drug by IV every 2-3 weeks for up to 2 years. The main goals are to che…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New antibody combo aims to outsmart High-Risk myeloma
Disease control Not yet recruitingThis study tests whether two bispecific antibodies (teclistamab and talquetamab) given in sequence can improve survival in 50 people with high-risk multiple myeloma. Participants receive chemotherapy, stem cell collection, and antibody treatments. Those with remaining cancer cell…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for hard-to-treat myeloma? early trial launches for QI-019B
Disease control Not yet recruitingThis early-stage study tests a new drug called QI-019B in 24 adults with multiple myeloma that has returned or not responded to at least two prior treatments. The main goal is to check safety and find the right dose, while also seeing if it helps control the cancer. This is not a…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New scan could spot myeloma spots better than current tests
Diagnosis Not yet recruitingThis study tests a new type of PET/CT scan that uses a special tracer (68Ga-BCMA nanobody) to find multiple myeloma lesions in the body. Researchers will compare it to the standard FDG-PET/CT scan to see if it detects more disease spots. The goal is to improve diagnosis, treatmen…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 26, 2026 09:35 UTC
-
Simple breathing tricks may boost heart health in blood cancer patients
Symptom relief Not yet recruitingThis study looks at whether adding special breathing exercises to a standard exercise program can improve heart and lung function in people with multiple myeloma. About 26 adults currently on a specific cancer drug will take part. One group will do the breathing exercises at home…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Symptom relief
Last updated May 26, 2026 09:58 UTC
-
Lifting weights, lifting spirits: new study tests exercise for myeloma patients
Symptom relief Not yet recruitingThis study looks at whether a 12-week resistance exercise program can improve quality of life, reduce frailty, and boost mental health in people with multiple myeloma. Fifty patients will be split into two groups: one doing supervised exercise and the other doing the same exercis…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: University of Salamanca • Aim: Symptom relief
Last updated May 26, 2026 09:52 UTC
-
Diet and exercise program aims to boost strength and quality of life in myeloma patients
Symptom relief Not yet recruitingThis study tests whether a 16-week lifestyle program focused on healthy eating and exercise can improve physical function, quality of life, and blood markers of aging in people with multiple myeloma. About 184 adults who have had myeloma for at least a year will take part. Partic…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC